News

The Hydrogenation Catalyst Market, Valued at US$ 3.7 billion in 2023, is anticipated to expand consistently and reach US$ 5.2 billion by 2031, registering a CAGR of 4.2% during the 2024 - 2031 ...
Scientists at ETH Zurich have developed a powerful method to look deep inside single-atom catalysts—materials where every ...
Oxygen evolution is considered one of the most energy-intensive steps in water electrolysis and is therefore a key factor for ...
"You're making a useful and valuable material that has downstream applications." Scientists discover breakthrough method to ...
Breakthrough CO₂ conversion technology achieves record-setting efficiency in producing high-value chemical fuels. As climate ...
A precious metal used everywhere from car exhaust systems to fuel cells, platinum is an incredibly efficient catalyst—but ...
BLOOMINGTON, Ill., June 10, 2025 /PRNewswire/ -- Chestnut Health Systems™ announced the launch of The Catalyst, a weekly podcast and newsletter created by its world-renowned research division ...
Does Catalyst Pharmaceutical (CPRX) have what it takes to be a top stock pick for momentum investors? Let's find out.
Kansas aims to fight addiction using opioid settlement funds. A new assessment suggests a tailored approach to tackle substance use across counties.
Catalyst Pharmaceuticals Announces Health Canada’s Acceptance of AGAMREE® New Drug Submission with Priority Review for Sub-Licensee Kye Pharmaceuticals ...
Catalyst Pharmaceuticals' current stock price only assumes historical momentum for existing drug portfolio continues. See why I rate CPRX a strong buy.